Mohs surgery is considered the gold standard in treating certain types of skin cancer – now there's a gold standard for treating challenging closures.
Complimentary Webinar Sponsored by MIMEDX
Mohs Surgery & Placental-Based Allografts:
A Review on Patient Selection, Current Evidence, and Documentation
EPIFIX® is a dehydrated human amnion/chorion membrane allograft that provides a protective barrier to support the healing cascade.
BENEFITS:
- Protects the wound bed to aid in the development of granulation tissue
- Provides a biocompatible human extracellular matrix (ECM)
- Retains 300+ regulatory proteins1-3
- Easy to apply
- 5-year shelf life and room temperature storage
CONSIDER EPIFIX WHEN:
- Patients are not good candidates for skin grafts or flaps
- Incisional repair options are limited
- An advanced therapy is needed for moderate and high-risk Mohs Micrographic Surgery (MMS) defects in cosmetically sensitive areas
NEW PEER REVIEWED RETROSPECTIVE STUDY IN FACIAL PLASTIC SURGERY & AESTHETIC MEDICINE4
This study is the first to compare the outcomes of placental allografts with skin grafts and flaps in the management of complex MMS.
Analysis of several outcomes in case-control comparisons between
autologous flap/FTSG groups and placental-based allografts:
CONCLUSION
Placental-based allografts can be helpful in supporting closure for MMS defects of the face, head, neck, and dorsal hand in a subset of patients who are not good candidates for traditional methods of autologous tissue reconstruction.
KEY CHALLENGES
Many factors may complicate healing in Mohs procedures and other dermal excisions and closures.
PATIENT FACTORS
- Thin Skin
- Poor Vascularture/Tissue Quality
- Advanced Age
- Comorbidities
LOCATION
- Scalp
- Ears
- Face/Visible Areas
- Shin or Lower Extremity
- Dorsal Hand
OPTIONS FOR EPIFIX USE
- Secondary intention wound closure
- An alternative for patients that are not candidates for skin grafts or flaps
- Location of wound in high tension area or highly visible
- Patients who decline surgery
CASE EXAMPLES
REIMBURSEMENT PROGRAMS COMMITTED TO THE SUCCESS OF YOUR TEAM
- 20+ Field Reimbursement Managers
- 20+ Insurance Verification (IVR) Specialists
- Flexible Options for IVR Submission
- Claims Review
- Appeals Support
- Obtain Health Plan Eligibility, Benefits, and Authorizations
- Available for On-Demand Education
A Patient Story
Cynthia’s physician performed Mohs surgery to remove her skin cancer. He applied EPIFIX to the area to help support the wound healing casacade.
CARING FOR CHALLENGING CLOSURES WHEN PATIENTS NEED IT MOST.
Contact us to learn more.
866.477.4219
2 MILLION+ ALLOGRAFTS DISTRIBUTED FOR PATIENTS
OVER 50 SCIENTIFIC AND CLINICAL PUBLICATIONS
#1 AMNIOTIC SKIN SUBSTITUTE**
